Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Exercise/Conversion of 7,500 DNTH shares, $134.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 7,500 | $134.1K |
| Jun 2, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 3,998 | $33.7K |
| Mar 14, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 7,998 | $67.5K |
| Feb 4, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 150,000 | n/a |
| Nov 15, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Exercise/Conversion | 83,978 | $708.8K |
| Sep 26, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 60,000 | n/a |
| Feb 4, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 150,000 | n/a |
| May 29, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 100,000 | n/a |
| Jan 26, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 120,000 | n/a |
| Sep 25, 2023 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Purchase | 2,000 | $26.4K |